In‐house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition

Hit, Lead & Candidate Discovery Drug repurposing has become a recent trend in drug development programs, where previously developed drugs are explored for hit and redeveloped into potential therapeutic agents for new diseases. Globally, in any drug development program, a series of molecules are...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug development research 2018-12, Vol.79 (8), p.383-390
Hauptverfasser: Ravithej Singh, L, Tripathi, Vikash C., Raj, Sneha, Kumar, Anoop, Gupta, Sampa, Horam, Soyar, Upadhyay, Akanksha, Kushwaha, Pragati, Arockiaraj, Jesu, Sashidhara, Koneni V., Pasupuleti, Mukesh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 390
container_issue 8
container_start_page 383
container_title Drug development research
container_volume 79
creator Ravithej Singh, L
Tripathi, Vikash C.
Raj, Sneha
Kumar, Anoop
Gupta, Sampa
Horam, Soyar
Upadhyay, Akanksha
Kushwaha, Pragati
Arockiaraj, Jesu
Sashidhara, Koneni V.
Pasupuleti, Mukesh
description Hit, Lead & Candidate Discovery Drug repurposing has become a recent trend in drug development programs, where previously developed drugs are explored for hit and redeveloped into potential therapeutic agents for new diseases. Globally, in any drug development program, a series of molecules are synthesized and evaluated for the hypothesized activity. Hits are developed into lead molecules or drugs, whereas the negative ones are shelved in the lab with no immediate use. We in this project took the previously sidelined small chemical molecules to the next level of utility, where previously developed in‐house small molecules library are tested for the unexplored biological relevant activity. As biofilm formation and quorum sensing play a vital role in bacterial pathogenesis, we believe that they could be one of the most effective targets for antimicrobial agents. In this study, we report the evaluation of 50 different compounds for anti‐biofilm and anti‐quorum sensing activity against Pseudomonas aeruginosa. Out of the screened compounds, three hydrazine‐carboxamide hybrid derivatives showed promising anti‐biofilm property and inhibition of pyocyanin production without any direct antimicrobial activity and cytotoxicity issues. Hydrazine‐carboxamide hybrids can be a new class and promising leads for further anti‐biofilm and anti‐virulence development against microbial infections.
doi_str_mv 10.1002/ddr.21458
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2116846583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2116846583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3538-ed58b1d7aee0b1e12ac948641cc4c214b7a202e53713cacbc187bd88a27a480c3</originalsourceid><addsrcrecordid>eNp10cFKHTEUBuAgLXprXfgCEnDTLkZzksxMxp1oq4LQUtr1kMmc643MJGMysb27brrvM_ZJGnvVhdBVIHz8HP6fkH1gR8AYP-77cMRBlmqLLIA1quC8aV6RBeM1L6RoYIe8ifGWMQCp1DbZEYw3UFf1gvy6cn9-_l75FJGaFY7W6IEOtgs6rGnAKYXJR-tuTugpNToj_KHHaUC69IF-jph6P3qnI9UY0o11Pmqq3Ww765d2GKk2s7238zp_9vQu-ZBGGtE9RFLrVtnN1ru35PVSDxH3Ht9d8u3jh69nl8X1p4urs9PrwohSqAL7UnXQ1xqRdYDAtWmkqiQYI00uoKs1ZxxLUYMw2nQGVN31Smlea6mYEbvk3SZ3Cv4uYZzb0UaDw6Ad5gpaDlApWZVKZHr4gt76FFy-LquykkI0gmX1fqNM8DEGXLZTsGPurgXWPmzT5m3af9tke_CYmLoR-2f5NEYGxxvw3Q64_n9Se37-ZRP5Fxiem8Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2156433930</pqid></control><display><type>article</type><title>In‐house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Ravithej Singh, L ; Tripathi, Vikash C. ; Raj, Sneha ; Kumar, Anoop ; Gupta, Sampa ; Horam, Soyar ; Upadhyay, Akanksha ; Kushwaha, Pragati ; Arockiaraj, Jesu ; Sashidhara, Koneni V. ; Pasupuleti, Mukesh</creator><creatorcontrib>Ravithej Singh, L ; Tripathi, Vikash C. ; Raj, Sneha ; Kumar, Anoop ; Gupta, Sampa ; Horam, Soyar ; Upadhyay, Akanksha ; Kushwaha, Pragati ; Arockiaraj, Jesu ; Sashidhara, Koneni V. ; Pasupuleti, Mukesh</creatorcontrib><description>Hit, Lead &amp; Candidate Discovery Drug repurposing has become a recent trend in drug development programs, where previously developed drugs are explored for hit and redeveloped into potential therapeutic agents for new diseases. Globally, in any drug development program, a series of molecules are synthesized and evaluated for the hypothesized activity. Hits are developed into lead molecules or drugs, whereas the negative ones are shelved in the lab with no immediate use. We in this project took the previously sidelined small chemical molecules to the next level of utility, where previously developed in‐house small molecules library are tested for the unexplored biological relevant activity. As biofilm formation and quorum sensing play a vital role in bacterial pathogenesis, we believe that they could be one of the most effective targets for antimicrobial agents. In this study, we report the evaluation of 50 different compounds for anti‐biofilm and anti‐quorum sensing activity against Pseudomonas aeruginosa. Out of the screened compounds, three hydrazine‐carboxamide hybrid derivatives showed promising anti‐biofilm property and inhibition of pyocyanin production without any direct antimicrobial activity and cytotoxicity issues. Hydrazine‐carboxamide hybrids can be a new class and promising leads for further anti‐biofilm and anti‐virulence development against microbial infections.</description><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>DOI: 10.1002/ddr.21458</identifier><identifier>PMID: 30291767</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antiinfectives and antibacterials ; Antimicrobial activity ; Antimicrobial agents ; anti‐biofilm ; Biofilms ; Biofilms - drug effects ; Biofilms - growth &amp; development ; Biological activity ; Cell Line ; Chemical compounds ; chemical repurposing ; Chemical synthesis ; Cytotoxicity ; Detection ; Dose-Response Relationship, Drug ; Drug development ; Drug Repositioning - methods ; Drugs ; Humans ; Hybrids ; Hydrazine ; Hydrazines ; hydrazine‐carboxamide ; Inhibition ; in‐house chemical library ; Microbial Sensitivity Tests - methods ; Microorganisms ; Organic chemistry ; P. aeruginosa ; Pathogenesis ; Pharmacology ; Pseudomonas aeruginosa ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - physiology ; Pyocyanin ; quorum sensing ; Quorum Sensing - drug effects ; Quorum Sensing - physiology ; Small Molecule Libraries - pharmacology ; Toxicity ; Virulence</subject><ispartof>Drug development research, 2018-12, Vol.79 (8), p.383-390</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3538-ed58b1d7aee0b1e12ac948641cc4c214b7a202e53713cacbc187bd88a27a480c3</citedby><cites>FETCH-LOGICAL-c3538-ed58b1d7aee0b1e12ac948641cc4c214b7a202e53713cacbc187bd88a27a480c3</cites><orcidid>0000-0002-9589-0709 ; 0000-0001-6337-6257 ; 0000-0001-6369-380X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fddr.21458$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fddr.21458$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30291767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ravithej Singh, L</creatorcontrib><creatorcontrib>Tripathi, Vikash C.</creatorcontrib><creatorcontrib>Raj, Sneha</creatorcontrib><creatorcontrib>Kumar, Anoop</creatorcontrib><creatorcontrib>Gupta, Sampa</creatorcontrib><creatorcontrib>Horam, Soyar</creatorcontrib><creatorcontrib>Upadhyay, Akanksha</creatorcontrib><creatorcontrib>Kushwaha, Pragati</creatorcontrib><creatorcontrib>Arockiaraj, Jesu</creatorcontrib><creatorcontrib>Sashidhara, Koneni V.</creatorcontrib><creatorcontrib>Pasupuleti, Mukesh</creatorcontrib><title>In‐house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition</title><title>Drug development research</title><addtitle>Drug Dev Res</addtitle><description>Hit, Lead &amp; Candidate Discovery Drug repurposing has become a recent trend in drug development programs, where previously developed drugs are explored for hit and redeveloped into potential therapeutic agents for new diseases. Globally, in any drug development program, a series of molecules are synthesized and evaluated for the hypothesized activity. Hits are developed into lead molecules or drugs, whereas the negative ones are shelved in the lab with no immediate use. We in this project took the previously sidelined small chemical molecules to the next level of utility, where previously developed in‐house small molecules library are tested for the unexplored biological relevant activity. As biofilm formation and quorum sensing play a vital role in bacterial pathogenesis, we believe that they could be one of the most effective targets for antimicrobial agents. In this study, we report the evaluation of 50 different compounds for anti‐biofilm and anti‐quorum sensing activity against Pseudomonas aeruginosa. Out of the screened compounds, three hydrazine‐carboxamide hybrid derivatives showed promising anti‐biofilm property and inhibition of pyocyanin production without any direct antimicrobial activity and cytotoxicity issues. Hydrazine‐carboxamide hybrids can be a new class and promising leads for further anti‐biofilm and anti‐virulence development against microbial infections.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antiinfectives and antibacterials</subject><subject>Antimicrobial activity</subject><subject>Antimicrobial agents</subject><subject>anti‐biofilm</subject><subject>Biofilms</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth &amp; development</subject><subject>Biological activity</subject><subject>Cell Line</subject><subject>Chemical compounds</subject><subject>chemical repurposing</subject><subject>Chemical synthesis</subject><subject>Cytotoxicity</subject><subject>Detection</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug development</subject><subject>Drug Repositioning - methods</subject><subject>Drugs</subject><subject>Humans</subject><subject>Hybrids</subject><subject>Hydrazine</subject><subject>Hydrazines</subject><subject>hydrazine‐carboxamide</subject><subject>Inhibition</subject><subject>in‐house chemical library</subject><subject>Microbial Sensitivity Tests - methods</subject><subject>Microorganisms</subject><subject>Organic chemistry</subject><subject>P. aeruginosa</subject><subject>Pathogenesis</subject><subject>Pharmacology</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - physiology</subject><subject>Pyocyanin</subject><subject>quorum sensing</subject><subject>Quorum Sensing - drug effects</subject><subject>Quorum Sensing - physiology</subject><subject>Small Molecule Libraries - pharmacology</subject><subject>Toxicity</subject><subject>Virulence</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10cFKHTEUBuAgLXprXfgCEnDTLkZzksxMxp1oq4LQUtr1kMmc643MJGMysb27brrvM_ZJGnvVhdBVIHz8HP6fkH1gR8AYP-77cMRBlmqLLIA1quC8aV6RBeM1L6RoYIe8ifGWMQCp1DbZEYw3UFf1gvy6cn9-_l75FJGaFY7W6IEOtgs6rGnAKYXJR-tuTugpNToj_KHHaUC69IF-jph6P3qnI9UY0o11Pmqq3Ww765d2GKk2s7238zp_9vQu-ZBGGtE9RFLrVtnN1ru35PVSDxH3Ht9d8u3jh69nl8X1p4urs9PrwohSqAL7UnXQ1xqRdYDAtWmkqiQYI00uoKs1ZxxLUYMw2nQGVN31Smlea6mYEbvk3SZ3Cv4uYZzb0UaDw6Ad5gpaDlApWZVKZHr4gt76FFy-LquykkI0gmX1fqNM8DEGXLZTsGPurgXWPmzT5m3af9tke_CYmLoR-2f5NEYGxxvw3Q64_n9Se37-ZRP5Fxiem8Y</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Ravithej Singh, L</creator><creator>Tripathi, Vikash C.</creator><creator>Raj, Sneha</creator><creator>Kumar, Anoop</creator><creator>Gupta, Sampa</creator><creator>Horam, Soyar</creator><creator>Upadhyay, Akanksha</creator><creator>Kushwaha, Pragati</creator><creator>Arockiaraj, Jesu</creator><creator>Sashidhara, Koneni V.</creator><creator>Pasupuleti, Mukesh</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9589-0709</orcidid><orcidid>https://orcid.org/0000-0001-6337-6257</orcidid><orcidid>https://orcid.org/0000-0001-6369-380X</orcidid></search><sort><creationdate>201812</creationdate><title>In‐house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition</title><author>Ravithej Singh, L ; Tripathi, Vikash C. ; Raj, Sneha ; Kumar, Anoop ; Gupta, Sampa ; Horam, Soyar ; Upadhyay, Akanksha ; Kushwaha, Pragati ; Arockiaraj, Jesu ; Sashidhara, Koneni V. ; Pasupuleti, Mukesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3538-ed58b1d7aee0b1e12ac948641cc4c214b7a202e53713cacbc187bd88a27a480c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antiinfectives and antibacterials</topic><topic>Antimicrobial activity</topic><topic>Antimicrobial agents</topic><topic>anti‐biofilm</topic><topic>Biofilms</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth &amp; development</topic><topic>Biological activity</topic><topic>Cell Line</topic><topic>Chemical compounds</topic><topic>chemical repurposing</topic><topic>Chemical synthesis</topic><topic>Cytotoxicity</topic><topic>Detection</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug development</topic><topic>Drug Repositioning - methods</topic><topic>Drugs</topic><topic>Humans</topic><topic>Hybrids</topic><topic>Hydrazine</topic><topic>Hydrazines</topic><topic>hydrazine‐carboxamide</topic><topic>Inhibition</topic><topic>in‐house chemical library</topic><topic>Microbial Sensitivity Tests - methods</topic><topic>Microorganisms</topic><topic>Organic chemistry</topic><topic>P. aeruginosa</topic><topic>Pathogenesis</topic><topic>Pharmacology</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - physiology</topic><topic>Pyocyanin</topic><topic>quorum sensing</topic><topic>Quorum Sensing - drug effects</topic><topic>Quorum Sensing - physiology</topic><topic>Small Molecule Libraries - pharmacology</topic><topic>Toxicity</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ravithej Singh, L</creatorcontrib><creatorcontrib>Tripathi, Vikash C.</creatorcontrib><creatorcontrib>Raj, Sneha</creatorcontrib><creatorcontrib>Kumar, Anoop</creatorcontrib><creatorcontrib>Gupta, Sampa</creatorcontrib><creatorcontrib>Horam, Soyar</creatorcontrib><creatorcontrib>Upadhyay, Akanksha</creatorcontrib><creatorcontrib>Kushwaha, Pragati</creatorcontrib><creatorcontrib>Arockiaraj, Jesu</creatorcontrib><creatorcontrib>Sashidhara, Koneni V.</creatorcontrib><creatorcontrib>Pasupuleti, Mukesh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ravithej Singh, L</au><au>Tripathi, Vikash C.</au><au>Raj, Sneha</au><au>Kumar, Anoop</au><au>Gupta, Sampa</au><au>Horam, Soyar</au><au>Upadhyay, Akanksha</au><au>Kushwaha, Pragati</au><au>Arockiaraj, Jesu</au><au>Sashidhara, Koneni V.</au><au>Pasupuleti, Mukesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In‐house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition</atitle><jtitle>Drug development research</jtitle><addtitle>Drug Dev Res</addtitle><date>2018-12</date><risdate>2018</risdate><volume>79</volume><issue>8</issue><spage>383</spage><epage>390</epage><pages>383-390</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><abstract>Hit, Lead &amp; Candidate Discovery Drug repurposing has become a recent trend in drug development programs, where previously developed drugs are explored for hit and redeveloped into potential therapeutic agents for new diseases. Globally, in any drug development program, a series of molecules are synthesized and evaluated for the hypothesized activity. Hits are developed into lead molecules or drugs, whereas the negative ones are shelved in the lab with no immediate use. We in this project took the previously sidelined small chemical molecules to the next level of utility, where previously developed in‐house small molecules library are tested for the unexplored biological relevant activity. As biofilm formation and quorum sensing play a vital role in bacterial pathogenesis, we believe that they could be one of the most effective targets for antimicrobial agents. In this study, we report the evaluation of 50 different compounds for anti‐biofilm and anti‐quorum sensing activity against Pseudomonas aeruginosa. Out of the screened compounds, three hydrazine‐carboxamide hybrid derivatives showed promising anti‐biofilm property and inhibition of pyocyanin production without any direct antimicrobial activity and cytotoxicity issues. Hydrazine‐carboxamide hybrids can be a new class and promising leads for further anti‐biofilm and anti‐virulence development against microbial infections.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30291767</pmid><doi>10.1002/ddr.21458</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9589-0709</orcidid><orcidid>https://orcid.org/0000-0001-6337-6257</orcidid><orcidid>https://orcid.org/0000-0001-6369-380X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0272-4391
ispartof Drug development research, 2018-12, Vol.79 (8), p.383-390
issn 0272-4391
1098-2299
language eng
recordid cdi_proquest_miscellaneous_2116846583
source MEDLINE; Wiley Online Library Journals
subjects Anti-Bacterial Agents - pharmacology
Antiinfectives and antibacterials
Antimicrobial activity
Antimicrobial agents
anti‐biofilm
Biofilms
Biofilms - drug effects
Biofilms - growth & development
Biological activity
Cell Line
Chemical compounds
chemical repurposing
Chemical synthesis
Cytotoxicity
Detection
Dose-Response Relationship, Drug
Drug development
Drug Repositioning - methods
Drugs
Humans
Hybrids
Hydrazine
Hydrazines
hydrazine‐carboxamide
Inhibition
in‐house chemical library
Microbial Sensitivity Tests - methods
Microorganisms
Organic chemistry
P. aeruginosa
Pathogenesis
Pharmacology
Pseudomonas aeruginosa
Pseudomonas aeruginosa - drug effects
Pseudomonas aeruginosa - physiology
Pyocyanin
quorum sensing
Quorum Sensing - drug effects
Quorum Sensing - physiology
Small Molecule Libraries - pharmacology
Toxicity
Virulence
title In‐house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T16%3A25%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%E2%80%90house%20chemical%20library%20repurposing:%20A%20case%20example%20for%20Pseudomonas%20aeruginosa%20antibiofilm%20activity%20and%20quorum%20sensing%20inhibition&rft.jtitle=Drug%20development%20research&rft.au=Ravithej%20Singh,%20L&rft.date=2018-12&rft.volume=79&rft.issue=8&rft.spage=383&rft.epage=390&rft.pages=383-390&rft.issn=0272-4391&rft.eissn=1098-2299&rft_id=info:doi/10.1002/ddr.21458&rft_dat=%3Cproquest_cross%3E2116846583%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2156433930&rft_id=info:pmid/30291767&rfr_iscdi=true